1. Home
  2. DVA vs ALLE Comparison

DVA vs ALLE Comparison

Compare DVA & ALLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • ALLE
  • Stock Information
  • Founded
  • DVA 1994
  • ALLE 2013
  • Country
  • DVA United States
  • ALLE Ireland
  • Employees
  • DVA N/A
  • ALLE N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • ALLE Diversified Commercial Services
  • Sector
  • DVA Health Care
  • ALLE Consumer Discretionary
  • Exchange
  • DVA Nasdaq
  • ALLE Nasdaq
  • Market Cap
  • DVA 12.6B
  • ALLE 11.0B
  • IPO Year
  • DVA 1995
  • ALLE N/A
  • Fundamental
  • Price
  • DVA $173.05
  • ALLE $132.09
  • Analyst Decision
  • DVA Hold
  • ALLE Hold
  • Analyst Count
  • DVA 5
  • ALLE 5
  • Target Price
  • DVA $153.40
  • ALLE $141.60
  • AVG Volume (30 Days)
  • DVA 533.7K
  • ALLE 646.1K
  • Earning Date
  • DVA 02-11-2025
  • ALLE 02-18-2025
  • Dividend Yield
  • DVA N/A
  • ALLE 1.08%
  • EPS Growth
  • DVA 41.03
  • ALLE 2.80
  • EPS
  • DVA 9.24
  • ALLE 6.50
  • Revenue
  • DVA $12,666,614,000.00
  • ALLE $3,724,000,000.00
  • Revenue This Year
  • DVA $6.18
  • ALLE $5.24
  • Revenue Next Year
  • DVA $3.58
  • ALLE $3.67
  • P/E Ratio
  • DVA $18.74
  • ALLE $20.47
  • Revenue Growth
  • DVA 6.34
  • ALLE 3.02
  • 52 Week Low
  • DVA $107.44
  • ALLE $113.27
  • 52 Week High
  • DVA $178.75
  • ALLE $156.10
  • Technical
  • Relative Strength Index (RSI)
  • DVA 70.13
  • ALLE 47.91
  • Support Level
  • DVA $167.57
  • ALLE $131.37
  • Resistance Level
  • DVA $170.80
  • ALLE $135.58
  • Average True Range (ATR)
  • DVA 3.66
  • ALLE 2.41
  • MACD
  • DVA 1.75
  • ALLE 0.73
  • Stochastic Oscillator
  • DVA 79.39
  • ALLE 61.98

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the us, and treats about 250,000 patients globally each year. Government payers dominate us dialysis reimbursement. DaVita receives about two thirds of us sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of the us patients treated, they represent nearly all of the profits generated by DaVita in the us dialysis business.

About ALLE Allegion plc

Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2023, Allegion generated 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy and Switzerland-based Dormakaba.

Share on Social Networks: